Ticker brief
TLX
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
6
authors 14d
4
crowd 14d
+0.2σ
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-10-06 → 2026-10-14 · now +0.10 (−1 bearish … +1 bullish)
Who spoke4
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @PrismMarketView | C | · | 2 | +0.35 |
| @CrweWorld | C | · | 2 | +0.18 |
| @PrismDM | A | -2.76 | 1 | +0.50 |
| @RedLeafSec | C | -0.23 | 1 | +0.30 |
Recent signals6of 6 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-14 | @CrweWorld | +0.10 | Telix announced conference highlights covering pivotal oncology trials and theranostics. | · | tweet ↗ |
| 2026-10-09 | @PrismMarketView | +0.35 | PROF and TLX partnered on PSMA-informed prostate-cancer care. | · | tweet ↗ |
| 2026-10-09 | @CrweWorld | +0.25 | Profound Medical and Telix entered a co-education agreement for prostate care. | · | tweet ↗ |
| 2026-10-06 | @RedLeafSec | +0.30 | Reports the ASX 200 close and percentage moves for its leading and lagging stocks. | · | tweet ↗ |
| 2026-10-06 | @PrismDM | +0.50 | Telix launched its FDA-approved Pixclara imaging agent in the US and administered initial doses. | · | tweet ↗ |
| 2026-10-06 | @PrismMarketView | +0.35 | Telix began U.S. commercial availability of FDA-approved Pixclara. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.